The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 0.00 (0.00%)
Spread: 0.50 (0.029%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sunday newspaper round-up: GlaxoSmithKline, Rare Earths, Amazon

Sun, 02nd May 2021 12:32

(Sharecast News) - Top investors in Glaxo Smith Kline are piling pressure on Dame Emma Walmsley after the activist New York hedge fund Elliott Management was revealed to have built a significant stake. Two top-20 investors in the drugs and consumer goods giant said that the chief executive's future was in doubt after four years of disappointing performance. One top-20 investor said there was "no desire to protect her" among institutional shareholders. Another said that Walmsley, 51, should step aside after her plan to break the business in two is carried out and hand over to her lieutenant, Luke Miels. - Sunday Times
Fears China will "turn off the taps" on Britain's green revolution has forced ministers to enter secret talks with seven commonwealth countries to mine their rare earths. Officials from the Department of International Trade and the Foreign Office have had meetings with representatives from Australia, Canada, Malawi and Tanzania in a bid to persuade them to supply rare earths, as well as critical metals such as lithium to the UK. Rare earths are found in abundance across the world, but are difficult to process and China controls around 90 per cent of the market. - Sunday Telegraph

Amazon is poised to seize upon the recent surge in interest in cryptocurrencies, bringing in a team of British financial regulation experts amid speculation it is on the brink of launching its own digital token. The US tech giant is understood to have poached at least six regulatory specialists from UK banking watchdog the Financial Conduct Authority (FCA) in the past two years. At least four of those have joined in the past year, taking up roles including public policy manager for regulation and chief compliance officer for payments divisions. - Sunday Telegraph

Britain will overtake Germany to become the largest economy in Europe by 2050, Transport Secretary Grant Shapps is predicting. He said Brexit has given Britain 'huge economic freedoms' to boost growth and he said he is putting aviation 'right at the heart' of the Government's mission to create Global Britain. - Financial Mail on Sunday

In another torrid year for the aviation industry, the coming month of May offers a little hope. The red-letter day in every UK airline executive's diary is 17 May, from which international leisure travel from Britain may be permitted. This week, ministers may finally divulge where and when holidaymakers can go, with a "green list" of countries that can be visited without quarantine on return. The Department for Transport insists it is on track to confirm, by "early May" as promised, whether planes can take off, and where to. - Guardian

Fund manager Ruffer has sold the majority of its holding in Bitcoin after Twitter posts by billionaire entrepreneur Elon Musk sent the price of the cryptocurrency soaring, The Mail on Sunday can reveal. Ruffer, a conservative asset management firm, surprised the City in November when it put 2.5 per cent of its customers' money - worth $600million (£433million) at the time - into Bitcoin. - Financial Mail on Sunday

Cosworth, the engineering firm best-known for producing powerful engines for high-performance Fords in the 1980s, is racing towards a float expected to value it at more than £100m. The Northamptonshire-based business has appointed Peel Hunt to advise on a stock market debut in London as soon as this summer. Cosworth, which employs almost 500 in the UK, Europe and North America, is part-owned by Kevin Kalkhoven, an Australian venture capitalist and motorsport entrepreneur, who bought the company from Ford in 2004 with his business partner Gerald Forsythe. - Sunday Telegraph

He has taken a battering for changing the name of FTSE100 funds giant Standard Life Aberdeen to Abrdn. But last night, chief executive Stephen Bird hit back, telling The Mail on Sunday that traditional fund management is 'in decline' - and revealing that the rebrand is part of a major strategy shift. The fund group, which manages £535billion, was mocked last week when it unveiled Abrdn. - Financial Mail on Sunday

Millions of employees could be given the chance to switch permanently to more flexible working arrangements under forthcoming guidance designed to encourage firms to make long-term some of the emergency changes ushered in by the pandemic. The government's flexible working taskforce is drawing up guidance - before the expected lifting of the remaining lockdown restrictions, including the requirement to work from home, on 21 June - to support the emergence of new, hybrid ways of working. For example, staff might come into offices only occasionally and work at home or at a neighbourhood cafe for the rest of the week. - Guardian
More News
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more
11 Dec 2023 08:28

GSK drug gets EU marketing backing for form of endometrial cancer

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.

Read more
11 Dec 2023 07:41

LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook

(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite.

Read more
11 Dec 2023 07:23

GSK endometrial cancer treatment gets Europe authorisation

(Sharecast News) - GSK announced on Monday that the European Commission has granted marketing authorisation for 'Jemperli', or dostarlimab, in combination with chemotherapy for certain endometrial cancers.

Read more
7 Dec 2023 12:54

THG backer Kelso pushes for demerger to trim "inherent" valuation gap

(Alliance News) - THG PLC investor Kelso Group Holdings PLC on Thursday reiterated its call for a demerger, which the shareholder believes will help close the "disparity" between the e-commerce firm's share price and its true value.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
27 Nov 2023 09:00

GSK announces positive results from Blenrep phase 3 blood cancer trial

(Alliance News) - GSK PLC on Monday said a phase 3 trial of belantamab mafodotin as a multiple myeloma treatment has produced positive headline results.

Read more
27 Nov 2023 08:02

GSK receives 'positive' headline results from phase III trial

(Sharecast News) - Drugmaker GSK announced on Monday that it had received positive headline results from a planned interim efficacy analysis from a phase III trial evaluating its elantamab mafodotin asset.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.